1981 Volume 10 Issue 2 Pages 632-634
As of October, private charges of chronic dialysis were covered by the government, therefore, number of chronic dialysis patients have significantly increased by year and year, and this tendency of increase is still kept in Japan. At the end of 1979, there were 32, 331 patients treated with chronic dialysis.
Number of patients required to blood purification are increased among chronic renal failure as well as acute renal failure, acute hepatic failure, detoxification and so on. Therefore, new device not depending upon dialysis is desired. We have developed hemoperfusion system combining in 1974. Since then, many clinical cases of chronic renal failure, acute renal failure, acute hepatic failure, detoxification and psoriasis were done in our clinic.
I. For chronic renal failure as chronic dialysis.
1. Short time dialysis:
This system is able to maintenance chronic dialysis patients treated with 5-6 hrs. hemodialysis to only 3 hours treatment.
2. Decrease of dialysis freqency:
This system can easily decrease dialysis freqency in one week from 3 times to 2 times in 4 patients during a half year.
3. Uremic pericarditis
The period of healing uremic pericarditis is significantly reduced by this system compared with ordinary hemodialysis.
II. For acute renal failure.
This system is applied for as an artificial reticuloendothelial system in the treatment of acute renal failure. The survival ratio of acute renal failure is significantly increased by this treatment compared with hemodialysis. (n=33)
In conclusion, this sytem of blood purification with hemoperfusion and hemodialysis simultaneously is very usuful for the treatment of chronic renal failure as well as acute one.
